Objective: Eosinophilic cystitis is a rare disease. We reviewed the literature for clinical presentation, diagnosis and therapeutic options to establish recommendations for diagnostic and therapeutic management.Methods: A pooled analysis was performed of 135 patients with eosinophilic cystitis presented in the literature. The evaluation included patient age, sex and race, presenting symptoms, diagnostic examinations, treatment and results, and complications.Results: The mean age at diagnosis was 41.6 years (range 5 days to 87 years). An equal distribution existed between males (44%) and females (35%), but in children (21%) boys were more often affected (14%) than girls (7%). The most common presenting symptoms were frequency (67%), dysuria (62%), gross/microscopic hematuria (68%), suprapubic pain (49%) and urinary retention (10%). All patients had a cystoscopy and biopsy; a biopsy is mandatory to establish the diagnosis. Positive urine cultures were found in 26% of the patients. Periferal eosinophilia was present in 43%. An intravenous urography was performed in 66%, ultrasonography in 15%, cystography in 23% and a CT scan in 10%. The majority of patients was treated with combinations of corticosteroids, antihistaminics and antibiotics (45%), avoiding of the suspected antigen (17%), transurethral resection of the lesions (9%), partial cystectomy (4%) or total cystectomy (4%). The success rates for the different treatments were variable: transurethral resection combined with corticosteroids, antihistaminics or antibiotics seemed most successful, while total cystectomy is reserved for patients with unresponsive disease and hematuria. The most common complications were dilation of the upper urinary tract (27%) and eosinophilic gastroenteritis (4.5%); all other complications occurred in less than 3% of the patients.Conclusion: Eosinophilic cystitis is equally distributed among the sexes, but in children boys are affected more often than girls. The presenting symptoms are frequency, dysuria, hematuria, suprapubic pain and urinary retention. The treatment of choise is (radical) transurethral resection of the lesions in the bladder and a combination of corticosteroids and antihistaminics. Antibiotics are given when a urinary tract infection is present, or when dilation of the upper urinary tract exists. Most patients are cured but recurrence is a frequent finding.

Keywords:
Eosinophilic cystitis, Diagnosis, Therapy, Etiology, Epidemiology
1.
Loeffler W: Zur Differentialdiagnose der Lungeninfiltrierungen. II. Über flüchtige Succedan–infiltrate (mit Eosinophilie). Beitr Klin Tuberk 1932;79:368–382.
2.
Brown EW: Eosinophilic granuloma of the bladder. J Urol 1960;83:665–668.
3.
Palubinskas AJ: Eosinophilic cystitis. Case report of eosinophilic infiltration of the urinary bladder. Radiology 1960;75:589–591.
4.
Hellstrom HR, Davis BK, Shonnard JW: Eosinophilic cystitis. A study of 16 cases. Am J Clin Pathol 1979;72:777–784.
5.
Littleton RH, Farah RN, Cerny JC: Eosinophilic cystitis: An uncommon form of cystitis. J Urol 1982;127:132–133.
6.
Zeitlhofer J, Bibus B: Zur Klinik und Pathologie des eosinophilen Harnblaseninfiltrates. Wien Klin Wochenschr 1967;79:958–961.
7.
Antonakopoulos GN, Newman J: Eosinophilic cystitis with giant cells. Arch Pathol Lab Med 1984;108:728–731.
8.
Aubert J, Doré B, Touchard G: La cystite à éosinophiles. J Urol 1983;89:65–70.
9.
Axelrod SL, Ring KS, Collins MH, Reilley EA, Hensle TW: Eosinophilic cystitis in children. Urology 1991;37:549–552.
10.
Barry KA, Jafri SZH: Eosinophilic cystitis: CT findings. Abdom Imaging 1994;19:272–273.
11.
Bauer SB, Kogan SJ: Vesical manifestations of chronic granulomatous disease in children. Its relation to eosinophilic cystitis. Urology 1991; 37:463–466.
12.
Botma JP, Burger EG, de Kock MLS: Eosiniphilic cystitis associated with Glanzmann’s thrombasthenia. A case report. S Afr Med J 1987;71:533–534.
13.
Bracis R, Sanders CV, Gilbert DN: Methicillin hemorrhagic cystitis. Antimicrob Agents Chemother 1977;12:438–439.
14.
Burhenne HJ, Carbone JV: Eosinophilic (allergic) gastroenteritis. Am J Roentgenol Radium Ther Nucl Med 1966;96:332–338.
15.
Cardini S, Smulevich E, Salvadori A, Lombardi M: Augmentation ileocystoplasty in a case of eosinophilic cystitis. Minerva Urol Nefrol 1997;49:219–223.
16.
Castillo J, Cartagena R, Montes M: Eosinophilic cystitis: A therapeutic challenge. Urology 1988;32:535–537.
17.
Chamberlin RO: Eosinophilic cystitis during pregnancy. Am J Obstet Gynecol 1992;166: 2829.
18.
Champion RH, Ackles RC: Eosinophilic cystitis. J Urol 1966;96:729–732.
19.
Chantepie G, Duquesne G, Creusy C: Cystopathies à éosinophiles. Ann Urol 1988;22:417– 420.
20.
Choe JM, Kirkemo AK, Sirls LT: Intravesical thiotepa–induced eosinophilic cystitis. Urology 1995;46:729–731.
21.
Constantinides C, Gavras P, Stinios J, Apostolaki C, Dimopoulos C: Eosinophilic cystitis: A rare case which presented as an invasive bladder tumor. Acta Urol Belg 1994;62:71–73.
22.
Dubucquoi S, Janin A, Desreumaux P, et al: Evidence for eosinophil activation in eosinophilic cystitis. Eur Urol 1994;25:254–258.
23.
Engler RJM, Weber CB, Turnicky R: Hypersensitivity to chromated catgut sutures: A case report and review of the literature. Ann Allergy 1986;56:317–320.
24.
Farber S, Vawter F: Clinical pathological conference. J Pediatr 1963;62:941–945.
25.
Felber E: Granuloma of the ureter. J Urol 1952;67:152–158.
26.
Ficarra V, Beltrami P, Giusti G, Tontodonati M, Zanon G, Malossini G: Perforation vésicale spontanée due à une cystite à éosinophiles: à propos d’une observation. Progr Urol 1997;7: 1012–1014.
27.
Foad BSI, Hess EV: Urinary bladder complications with cyclophosphamide therapy. Arch Intern Med 1976;136:616–619.
28.
Fossgreen J: Eosinophile Granulomatosis. Ein ungewöhnlicher Fall mit Veränderungen im Darm, den Lymphknoten des Mesenteriums, den Ovarien, im Uterus, der Harnblase und im Herzen. Acta Pathol Microbiol Scand 1962; 56:143–154.
29.
Frensilli FJ, Sacher EC, Keegan GT: Eosinophilic cystitis: Observations on etiology. J Urol 1972;107:595–596.
30.
Gelabert Mas A, Arango O, Rosales A, Coronado J, Moreno A: Eosinophilic cystitis and allergy to mitomycin–C. Acta Urol Belg 1990; 58:65–71.
31.
Gerharz EW, Grueber M, Melekos MD, Weingaertner K, Barth P, Riedmiller H: Tumorforming eosinophilic cystitis in children. Eur Urol 1994;25:138–141.
32.
Goldstein M: Eosinophilic cystitis. J Urol 1971;106:854–857.
33.
Gregg JA, Utz DC: Eosinophilic cystitis associated with eosinophilic gastroenteritis. Mayo Clin Proc 1974;49:185–187.
34.
Haberkern CM, Christie DL, Haas JE: Eosinophilic gastroenteritis presenting as ileocolitis. Gastroenterology 1978;74:896–899.
35.
Hansen MV, Kristensen PB: Eosinophilic cystitis simulating invasive bladder carcinoma. Scand J Urol Nephrol 1993;27:275–277.
36.
Hansman DJ, Brown JM: Eosinophilic cystitis: A case associated with possible hydatid infection. Med J Aust 1974;2:563–565.
37.
Hellstrom HR, Davis BK, Shonnard JW, Macpherson TA: Eosinophilic pyeloureteritis: Report of a case. J Urol 1979;122:833–834.
38.
Horner SA, Weingarten JL: Eosinophilic cystitis in a renal allograft recipient. J Urol 1990; 144:342–343.
39.
Horowitz J, Slavin S, Pfau A: Chronic renal failure due to eosinophilic cystitis. Ann Allergy 1972;30:502–506.
40.
Inglis A, Tolley DA, Grigor KM: Allergy to mitomycin C complicating topical administration for urothelial cancer. Br J Urol 1987;59: 547–549.
41.
Johansson SL, Smout MS, Taylor RJ: Eosinophilic cystitis associated with symptomatic ureteral involvement. J Urol Pathol 1993;1: 69–77.
42.
Johnson HW, Elliot GB, Israels S, Balfour J: Granulomatous cystitis in children, bilharzia like, occurring in British Columbia. Pediatrics 1967;40:808–815.
43.
Kessler WO, Clark PL, Kaplan GW: Eosinophilic cystitis. Urology 1975;6:499–501.
44.
Ladocsi LT, Sullivan B, Hanna MK: Eosinophilic granulomatous cystitis in children. Urology 1995;46:732–735.
45.
Madersbacher H, Bartsch G: Eosinophile Infiltrate der Harnblase. Ein Beitrag zur granulomatösen Zystitis. Urol Int 1972;27:149–159.
46.
Marshall FF, Middleton AW: Eosinophilic cystitis. J Urol 1974;112:335–337.
47.
Mitas JA, Thompson T: Ureteral involvement complicating eosinophilic cystitis. Urology 1985;26:67–70.
48.
Motzkin D: Nonsteroidal anti–inflammatory drugs in the treatment of eosinophilic cystitis. J Urol 1990;144:1464–1466.
49.
Nakada T, Ishikawa S, Sakamota M, et al: N–(3′,4′–dimethoxycinnamoyl)anthranillic acid, an antiallergic compound, induced eosinophilic cystitis. Urol Int 1986;41:457–464.
50.
Nkposong EO, Attah EB: Eosinophilic cystitis. Eur Urol 1978;4:274–278.
51.
Oh SJ, Chi JG, Lee SE: Eosinophilic cystitis caused by vesical sparganosis: A case report. J Urol 1993;149:581–583.
52.
Okada H, Minayoshi K, Goto A: Two cases of eosinophilic cystitis induced by tranilast. J Urol 1992;147:1366–1368.
53.
Okafo BA, Jones HW, Dow W, Kiruluta HG: Eosinophilic cystitis: Pleiomorphic manifestations. Can J Surg 1985;28:17–18.
54.
Perlmutter AD, Edlow JB, Kevy SV: Toxocara antibodies in eosinophilic cystitis. J Pediatr 1968;73:340–344.
55.
Peterson NE: Eosinophilic cystitis. Urology 1985;26:167–169.
56.
Peterson NE, Silverman A, Campbell JB: Eosinophilic cystitis and coexistent eosinophilic gastroenteritis in an infant. Pediatr Radiol 1989;19:484–485.
57.
Platt ML, Kiesling VJ, Vaccaro JA: Eosinophilic ureteritis associated with eosinophilic cholangitis. J Urol 1990;144:127–129.
58.
Popert RJM, Ramsay JWA, Owen RA, Fisher C, Hendry WF: Eosinophilic cystitis mimicking invasive bladder tumor: Discussion paper. J R Soc Med 1990;83:776–778.
59.
Rubin L, Pincus MB: Eosinophilic cystitis: The relationship of allergy in the urinary tract to eosinophilic cystitis and the pathophysiology of eosinophilia. J Urol 1974;112:457–460.
60.
Scully RE, Mark EJ, McNeely WF, Ebeling SH: Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. N Engl J Med 1998;339:616–622.
61.
Sekine H, Kojima S, Ohya K: Eosinophilic cystitis masquerading as invasive bladder cancer. Urol Int 1998;61:128–129.
62.
Sidh SM, Smith SP, Silber SB, Young JD: Eosinophilic cystitis: Advanced disease requiring surgical intervention. Urology 1980;15: 23–26.
63.
Snow BW, Garett RA: Retroperitoneal fibrosis in children (eosinophilic and idiopathic). Urology 1984;23:569–572.
64.
Sujka SK, Fisher JE, Greenfield SP: Eosinophilic cystitis in children. Urology 1992;40: 262–264.
65.
Sutphin M, Middleton AW: Eosinophilic cystitis in children: A self–limited process. J Urol 1984;132:117–119.
66.
Tauscher JW, Shaw DC: Eosinophilic cystitis. Clin Pediatr 1981;20:741–743.
67.
Thijssen A, Gerridzen RG: Eosinophilic cystitis presenting as invasive bladder cancer: Comments on pathogenesis and management. J Urol 1990;144:977–979.
68.
Ülker V, Apaydin E, Gürsan A, Özyurt C, Kandiloglu G: Eosinophilic cystitis induced by mitomycin–C. Int Urol Nephrol 1996;28:755– 759.
69.
Uyama T, Moriwaki S, Aga Y, Yamamoto A: Eosinophilic ureteritis? Regional ureteritis with marked infiltration of eosinophils. Urology 1981;18:615–617.
70.
Vetter V, Beck JD, Böwing B, Rösch W: Case of the month. A 2–year–old girl with urinary stasis and a bladder mass. Eur J Pediatr 1995; 154:935–936.
71.
Watson HS, Singh EO, Hermans MR, Coffield KS, Keegan GT: Recurrent eosinophilic cystitis: A case responsive to steroids. J Urol 1992; 147:689–691.
72.
Weisberg SC, Crosson JT: Eosinophilic gastroenteritis. Report of a case of thirty–two years’ duration. Am J Dig Dis 1973;18:1005– 1014.
73.
Wenzl JE, Greene LF, Harris LE: Eosinophilic cystitis. J Pediatr 1964;64:746–749.
74.
Witters G, Baert L, d’Hoedt M, Tanghe W: Eosinophilic granuloma of the bladder. Urology 1991;37:72–74.
75.
Kopf A, Boue F, Delfraissy JF, Charton M, Brisset JM, Duclos JM, Galanaud P: Cystites à éosinophiles d’origine allergique. Presse Méd 1984;13:83–86.
76.
Leibovitch I, Heyman Z, Ben Chaim J, Goldwasser B: Ultrasonographic detection and control of eosinophilic cystitis. Abdom Imaging 1994;19:270–271.
77.
Hirano S, Kobayashi K, Yamagutchi K, Ueki O, et al: Eosinophilic cystitis: A report of 2 cases. Acta Urol Jpn 1983;29:1229–1237.
78.
Shinno Y, Tsubo S, Kumagai A, Sakashita S, Koyanagi T, Terashima M: Chronic cystitis in seven asthmatic patients treated with tranilast. Jpn J Clin Urol 1985;39:441–444.
79.
Kurosawa I, Jimbo S: Drug induced cystitis due to tranilast: A report of two cases. Jpn J Clin Urol 1985;39:149–151.
80.
Fujimoto H, Tanaka M, Niitsu S, Ishii Z: A case of eosinophilic cystitis. Jpn J Clin Urol 1985;39:145–147.
81.
Ueda M, Ohta T, Miyagawa I: Eosinophilic cystitis in asthmatic patient treated with tranilast. Jpn J Clin Urol 1985;39:875–877.
82.
Nishida T, Kumakay I, Ogoshi R: Four cases of cystitis induced by the anti–allergic drug tranilast. Acta Urol Jpn 1985;31:1813–1817.
83.
Lose G, Frandsen B, Holm–Bentzen M, Larsen S, Jacobsen F: Urine eosinophil cationic protein in painful bladder disease. Br J Urol 1987; 60:39–42.
84.
French AJ: Hypersensitivity in the pathogenesis of the histopathologic changes associated with sulfonamide chemotherapy. Am J Pathol 1946;22:679–701.
85.
Pastinszky I: The allergic diseases of the male genitourinary tract with special reference to allergic urethritis and cystitis. Urol Int 1959;9: 288–305.
86.
Powell NB, Powell EB, Thomas OC, Queng JT, McGovern JP: Allergy of the lower urinary tract. J Urol 1972;107:631–634.
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.